Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Martie Miranda one of only 10 SATI accredited sign language interpreters in South Africa
2015-04-23

Martie Miranda
Photo: Stefan Lotter

The University of the Free State is privileged to have one of the top South African Sign Language (SASL) Interpreters as a staff member at the Unit for Students with Disabilities (USD).

Martie Miranda recently passed the accreditation exam of the South African Translators Institute (SATI), joining Dr Philemon Akach, previous HOD of the South African Sign Language Department of the UFS, in becoming one of only 10 SASL interpreters to be SATI accredited.

SATI is a professional association for language practice professionals in South Africa. Voluntary accreditation is offered at a professional level, ensuring a high standard of language practice. The system has become widely recognised, and is used as a recommendation or prerequisite for job applications by a number of institutions, including the South African government, particularly after the infamous ‘Jantjies incident’ with the funeral service of the late President Nelson Mandela.

Martie, a proud Child of Deaf Adults (CODA), has 18 years’ experience in SASL interpreting, lip speaking interpreting, and community interpreting as well as 15 years’ experience of conference and seminar interpreting. She boasts a Level 2 Advanced Interpreting qualification, and she has been mentoring Level 1 SASL interpreters for the past six years. Her extensive interpreting experience on a national and international level also includes Deafblind interpreting as well as Court and Legislature interpreting. She has interpreted three theatre productions, and has been coordinating the SASL services at the UFS since January 2009. She is responsible for the student management of all the hearing-impaired students at the USD.

Martie completed her BML degree (cum laude) at the UFS Business School in 2013, and received the award for top achiever in the programme during her final year. She will enrol for her MBA at the UFS Business School in July 2015.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept